|
| Admission | Discharge | 6 weeks after discharge | 12 weeks after discharge |
|
Blood count | | | | |
Leukocyte (K/μL) | 1.9 | 5.2 | 9.9 | 5.9 |
Hemoglobin (g/dL) | 6.5 | 8 | 8.3 | 10.9 |
Hematocrit | 19.2 | 23.7 | 26.3 | 32.5 |
Platelets (K/μL) | 14 | 38 | 130 | 236 |
|
Chemistry | | | | |
Sodium (mmol/L) | 127 | 135 | 135 | 141 |
Potassium (mmol/L) | 4.6 | 5.2 | 4.1 | 4.2 |
Chloride (mEq/L) | 104 | 109 | 106 | 106 |
Bicarbonate (mmol/L) | 21 | 22 | 22 | |
Blood urea nitrogen (mg/mL) | 23 | 43 | 29 | 16 |
Creatinine (mg/mL) | 1.42 | 1.11 | 1.03 | 1.05 |
Glomerular filtration rate | 56 | 75 | 81 | 79 |
Calcium (mg/mL) | 5.8 | 7 | 7.6 | 8.4 |
Glucose (mg/mL) | 100 | 88 | 130 | 76 |
Aspartate aminotransferase (U/L) | 19 | | 17 | 18 |
Alanine aminotransferase (U/L) | 33 | | 21 | 10 |
Alkaline phosphatase (U/L) | 47 | | 53 | 44 |
Total bilirubin (mg/dL) | 0.2 | | 0.2 | 0.2 |
Total protein (g/dL) | 4.4 | 4.8 | 4.3 | 4.6 |
Albumin (g/dL) | 1.4 | 1.5 | 2.3 | 2.4 |
Ferritin (ng/mL) | 6542 | 1027 | 527 | 330 |
Lactate dehydrogenase (U/L) | 336 | 252 | 275 | 187 |
Haptoglobin (mg/dL) | <8 | 20 | <8 | 52 |
Thyroid-stimulating hormone (uIU/mL) | 7.5 | | | |
Creatine kinase (U/L) | 105 | | | |
C-reactive protein (mg/L) | 0.67 | | | |
Vitamin B12 (pg/mL) | 414 | | | |
Triglycerides | 327 | | | |
|
Coagulation | | | | |
Activated partial thromboplastin time (seconds) | 31.5 | | | |
Prothrombin time (seconds) | 14.2 | | | |
International normalized ratio | 1.1 | | | |
Dilute Russell’s viper venom time (seconds) | 40.5 | | | |
|
Others | | | | |
Erythrocyte sedimentation rate (mm/hr) | 137 | | | |
Complement 3 (mg/dL) | 14 | | | |
Complement 4 (mg/dL) | 3 | | | |
Direct antiglobulin test, broad-spectrum Coomb’s serum | Positive | | | |
Direct antiglobulin test, anti-IgG Coomb’s serum | Positive | | | |
Direct antiglobulin test, anti-C3 Coomb’s serum | Negative | | | |
Antibody identification | Cold autoantibody | | | |
|
Urine study | | | | |
Protein | 3+ | 3+ | 1+ | 1+ |
Protein/creatinine ratio | 7.04 | | | |
Blood | 3+ | 3+ | 2+ | 2+ |
Red blood cell (/HPF) | 60 | | 11–25 | 11–25 |
White blood cell (/HPF) | 7 | | 0–4 | 0–4 |
|
Autoimmune serology | | | | |
Antinuclear antibody | 1 : 640 (homogeneous pattern) | | | |
Anti-dsDNA antibody (IU/ml) | 195 | | | |
Anti-Ro antibody (AU/mL) | 12 | | | |
Anti-ribonucleoprotein antibody (AI) | 0.5 | | | |
Anti-Smith antibody (AI) | 0.4 | | | |
Anti-Scl 70 antibody (AI) | 0.2 | | | |
Rheumatoid factor (IU/mL) | <15 | | | |
Anti-cyclic citrullinated peptide antibody (units) | 19 | | | |
Anticardiolipin antibody, IgM (U/mL) | 22 | | | |
Anticardiolipin antibody, IgG (U/mL) | 48 | | | |
Anticardiolipin antibody, IgA (U/mL) | <9 | | | |
Beta-2 glycoprotein I antibody, IgM (GPI IgM units) | <9 | | | |
Beta-2 glycoprotein I antibody, IgG (GPI IgG units) | 55 | | | |
Beta-2 glycoprotein I antibody, IgA (GPI IgA units) | 9 | | | |
|